NCT06744140View on ClinicalTrials.gov

Role of MRI Breast in Detection of Ductal Carcinoma in Situ

Active, not recruitingOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

July 1, 2024

Study Completion Date

March 21, 2025

Conditions
Carcinoma in Situ
Interventions
DIAGNOSTIC_TEST

Magnetic Resonance Imaging (MRI)

To Evaluate the breast Magnetic Resonance Imaging (MRI) in detecting Ductal Carcinoma In Situ (DCIS) lesions among high-risk breast cancer patients while keeping the histopathology as a GOLD standard

Trial Locations (1)

Unknown

INMOL hospital, Lahore

All Listed Sponsors
lead

Superior University

OTHER

NCT06744140 - Role of MRI Breast in Detection of Ductal Carcinoma in Situ | Biotech Hunter | Biotech Hunter